U.S. Markets open in 9 hrs 23 mins

Aspen Group, Inc. (ASPU)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.28+0.04 (+0.76%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.24
Open5.25
Bid5.28 x 800
Ask5.31 x 800
Day's Range5.03 - 5.38
52 Week Range5.03 - 13.16
Volume393,379
Avg. Volume225,690
Market Cap131.738M
Beta (5Y Monthly)0.74
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Aspen Group Reports 33% Revenue Growth for the Third Quarter of Fiscal Year 2021
    GlobeNewswire

    Aspen Group Reports 33% Revenue Growth for the Third Quarter of Fiscal Year 2021

    BSN Pre-licensure and USU (primarily MSN-FNP) units deliver 51% of consolidated revenue BSN Pre-licensure program has launched in three new metros in the past five months NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Aspen Group, Inc. ("Aspen Group" or "AGI") (Nasdaq: ASPU), an education technology holding company, today announced financial results for its 2021 fiscal third quarter ended January 31, 2021. Third Quarter and Year to Date Fiscal Year 2021 Summary Results Three Months EndedNine Months Ended$ in millions, except per share data(rounding differences may occur)January 31, 2021January 31, 2020January 31, 2021January 31, 2020Revenue$16.6 $12.5 $48.8 $35.0 GAAP Gross Profit1$8.7 $7.1 $27.0 $20.5 GAAP Gross Margin (%)1 52% 57% 55% 59% Operating Income (Loss)($2.8)($1.7)($5.9)($3.7)Net Income (Loss)($2.8)($2.3)($8.1)($5.0)Earnings (Loss) per Share($0.11)($0.12)($0.35)($0.26)Adjusted Net Income (Loss)2($2.1)($0.9)($3.2)($2.5)Adjusted Earnings (Loss) per Share2 ($0.09)($0.05)($0.14)($0.13)EBITDA2($2.2)($1.1)($4.5)($1.6)Adjusted EBITDA2($0.9)$0.2 $0.6 $1.5 1 GAAP gross profit calculation includes marketing and promotional costs, instructional costs & services, and amortization expense. 2 See reconciliations of GAAP to Non-GAAP financial measures under "Non-GAAP–Financial Measures" below.“We delivered strong revenue growth of 33% in the third quarter despite moderate headwinds from COVID-19 combined with traditionally lower seasonality,” said Michael Mathews, Chairman and CEO of AGI. “Our Pre-licensure BSN and USU (primarily MSN-FNP) units are our highest growth and highest LTV businesses and now make up 51% of our consolidated revenue. We launched our BSN Pre-Licensure program in three new metros over the past five months. The start-up costs we face with each new campus including real estate leases, added instructional costs, and new marketing costs impacted our short-term profitability. However, the strong performance of the Phoenix metro BSN Pre-Licensure program, which delivered net income and EBITDA of $1.8 million for a 52% EBITDA margin, helped to offset the new campus start-up operating expenses, and demonstrates the future leverage from this unit.” Third Quarter Fiscal Year 2021 Financial and Operational Results vs. Third Quarter Fiscal Year 2020: Third Quarter Bookings1 and Average Revenue Per Enrollment (ARPU)2 Three Months EndedThree Months Ended $ in millions, except ARPU (rounding differences may occur)January 31, 2021 EnrollmentsJanuary 31, 2021 BookingsJanuary 31, 2020 EnrollmentsJanuary 31, 2020 BookingsYear-over-Year % Change of TotalBookings & ARPUAspen University1,593$23.51,371$19.9 USU536$9.6375$6.7 Total2,129$33.01,746$26.524% ARPU $15,513 $15,1992% 1Bookings are defined by multiplying LTV by new student enrollments for each operating unit. 2Average Revenue Per Enrollment (ARPU) is defined by dividing total Bookings by total new student enrollments for each operating unit. Higher bookings drove an average revenue per enrollment (ARPU) increase of 2%, reflecting a mix shift towards higher LTV nursing licensure degree programs, partially offset by the planned flattening of first year online pre-requisite student enrollments at the Phoenix BSN pre-licensure campuses. Revenue increased 33% to $16.6 million for Q3 fiscal 2021 as compared to $12.5 million for Q3 fiscal 2020. USU accounted for 29% and Aspen University's BSN Pre-Licensure program accounted for 22% of overall Company revenues for Q3 fiscal 2021. Gross profit and gross margin were $8.7 million and 52%, respectively, for Q3 fiscal 2021 versus $7.1 million and 57%, respectively, for Q3 fiscal 2020. For Q3 fiscal 2021, instructional costs were $3.9 million or 24% of consolidated revenue and marketing costs were $3.6 million or 22% of consolidated revenue. For Q3 fiscal 2020, instructional costs were $2.6 million or 21% of consolidated revenue and marketing costs were $2.5 million or 20% of consolidated revenue. The increase in instructional costs as a percent of revenue were primarily due to the hiring of full-time faculty for the Company’s Pre-licensure program at the Phoenix main campus preparing for double cohorts starting in February 2021, as well as new campuses in Tampa, FL and Austin, TX. For the third quarter of fiscal year 2021, net loss applicable to shareholders was ($2.8 million) or basic net loss per share of ($0.11) versus net loss applicable to shareholders of ($2.3 million) or basic net loss per share of ($0.12) in the prior year period. Aspen University generated $1.4 million of net income for Q3 fiscal 2021, and USU generated $0.3 million of net income in Q3 fiscal 2021. AGI corporate incurred $4.5 million of operating expenses for Q3 fiscal 2021. Adjusted Net Loss, a non-GAAP financial measure, was ($2.1 million) for the third quarter of fiscal year 2021 as compared to Adjusted Net Loss of ($0.9 million) in the prior year period. Adjusted Loss Per Share, a non-GAAP financial measure, was ($0.09) for the third quarter of fiscal year 2021 as compared to Adjusted Loss per Share of ($0.05) in the prior year period. EBITDA, a non-GAAP financial measure, was ($2.2 million) or (13%) margin in Q3 fiscal 2021 as compared to an EBITDA of ($1.1 million) or (9%) margin in Q3 fiscal 2020. Adjusted EBITDA, a non-GAAP financial measure, was ($0.9 million) or (5%) margin in Q3 fiscal 2021 as compared to an Adjusted EBITDA of $0.2 million or 2% margin in Q3 fiscal 2020. Three Months Ended January 31, 2021*As a percentage of revenue attributable to each unitAspen UniversityUSUAGI CorporateConsolidatedGAAP Gross Profit Margin* 54% 53% NA 52% Instructional costs and services* 22% 27% NA 24% Marketing and promotional costs* 20% 21% NA 22% Net income$1.4 $0.3 ($4.5) ($2.8) EBITDA1$1.9 $0.4 ($4.5) ($2.2) EBITDA margin* 16% 8% NA (13%) Adjusted EBITDA1$2.5 $0.5 ($3.8) ($0.9) Adjusted EBITDA margin* 21% 10% NA (5%) 1 See reconciliations of GAAP to Non-GAAP financial measures under "Non-GAAP–Financial Measures" below. COVID-19 Update and Fourth Quarter Revenue Forecast In our third fiscal quarter ending January 31, 2021, which has been historically a seasonally slower quarter given it falls during the holiday months of November and December, Aspen University saw approximately 4% less course registrations than seasonally expected in our Aspen Nursing + Other unit (which equates to approximately $110,000 of reduced revenue per month or $330,000 in the quarter relative to the Company’s forecast). USU’s MSN-FNP program also saw a similar course start decline of approximately 4% in the quarter relative to the Company’s forecast, which equates to approximately $190,000 of reduced revenue for the quarter. We believe COVID-19 ‘Wave Two’ was the key factor in the lower course starts than forecasted at both universities in the quarter, given that all the states in the country are now affected – not just some of the major metros. Our predominant student demographic of Registered Nurses (as of January 31, 2021, 9,277 of the Company’s 13,407 total active students or 69% are RNs) has been especially overwhelmed over the past several months, so this is not unexpected. The status and/or reasons identified by our predominantly RN student body who constitute the lower course starts over the past several months fall into four categories: 1) rescheduling of upcoming course registrations to a later date, 2) requests for temporary leave of absence, 3) requests to delay placement into preferred clinical location timed with the facility accepting new in-person students again, and 4) course or program withdrawal requests due to family emergencies, pressures at work/emotional distress and lack of time. The Company expects the COVID ‘Wave Two’ effect to continue throughout the current fourth fiscal quarter, as we are forecasting approximately 4.5% less course registrations than seasonally expected in our Aspen Nursing + Other unit and USU’s MSN-FNP program. Consequently, in our current fourth fiscal quarter ending April 30, 2021, we are expecting year-over-year revenue growth in the range of 31% - 33% ($18.4 - $18.7 million), versus the Company’s previous forecast of 36% growth or $19.1 million. Liquidity At January 31, 2021, the Company reported cash and cash equivalents of $10.0 million and restricted cash of $3.4 million. The Company used cash of ($3.2 million) in operations in the third quarter of fiscal year 2021, as compared to using ($1.8 million) in same period last year. For the nine month period of fiscal year 2021, cash used from operations is $5.3 million or an average of $1.8 million per quarter. Conference Call: Aspen Group will host a conference call to discuss its third quarter fiscal year 2021 financial results and business outlook on Tuesday, March 16, 2021, at 4:30 p.m. (ET). Aspen Group will issue a press release reporting results after the market closes on that day. The conference call can be accessed by dialing toll-free (844) 452-6823 (U.S.) or (731) 256-5216 (international), passcode 9391007. Subsequent to the call, a transcript of the audiocast will be available from the Company’s website at ir.aspen.edu. There will also be a seven day dial-in replay which can be accessed by dialing toll-free (855) 859-2056 or (404) 537-3406 (international), passcode 9391007. Non-GAAP – Financial Measures: This press release includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of AGI nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP. Our management uses and relies on Adjusted Net Income (Loss), Adjusted Earnings (Loss) Per Share, EBITDA and Adjusted EBITDA, EBITDA margin and Adjusted EBITDA margin, which are non-GAAP financial measures. We believe that management, analysts and shareholders benefit from referring to the following non-GAAP financial measures to evaluate and assess our core operating results from period-to-period after removing the impact of items that affect comparability. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described below. We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between AGI and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each Company under applicable SEC rules.AGI defines Adjusted Net Income (Loss) as net earnings (loss) from operations adding back non-recurring charges and stock-based compensation expense as reflected in the table below. Nine months fiscal 2021 includes – non-cash stock-based compensation expense of $1.2 million related to the accelerated amortization expense for the price vesting of Executive RSUs and non-recurring charges includes a $1.4 million interest expense charge related to the conversion of $10 million Convertible Notes and $0.1 million of interest expense which arose from the acceleration of amortization arising from the exercise of warrants issued to a lender. The following table presents a reconciliation of net loss and earnings (loss) per share to Adjusted Net Income (Loss) and Adjusted Earnings (Loss) Per Share: Three Months Ended January 31, Nine Months Ended January 31, 2021 2020 2021 2020Earnings (loss) per share$(0.11) $(0.12) $(0.35) $(0.26)Weighted average number of common stock outstanding*24,544,334 19,420,987 23,354,036 19,046,558 Net loss$(2,815,266) $(2,281,052) $(8,128,987) $(4,994,502)Add back: Stock-based compensation701,170 347,210 3,019,828 1,341,245 Non-recurring charges— 1,010,123 1,906,203 1,143,072 Adjusted Net (Loss)$(2,114,096) $(923,719) $(3,202,956) $(2,510,185) Adjusted (Loss) per Share$(0.09) $(0.05) $(0.14) $(0.13) *Same share count used for GAAP and non-GAAP financial measures. AGI defines Adjusted EBITDA as EBITDA excluding: (1) bad debt expense; (2) stock-based compensation; and (3) non-recurring charges such as stock based compensation and other items. Included in nine months fiscal 2021 is –non-cash stock-based compensation expense of $1.2 million related to the accelerated amortization expense for the price vesting of the Executive RSUs. The above items are excluded from our Adjusted EBITDA measure because these items are non-cash in nature. Adjusted EBITDA is an important measure of our operating performance because it allows management, analysts and investors to evaluate and assess our core operating results from period-to-period after removing the impact of items that affect comparability. The following table presents a reconciliation of consolidated net loss to EBITDA and Adjusted EBITDA: Three Months Ended January 31, Nine Months Ended January 31, 2021 2020 2021 2020Net loss$(2,815,266) $(2,281,052) $(8,128,987) $(4,994,502)Interest expense, net33,436 570,020 2,018,176 1,416,784 Taxes10,460 98,173 45,090 243,035 Depreciation and amortization535,273 475,393 1,552,254 1,710,192 EBITDA(2,236,097) (1,137,466) (4,513,467) (1,624,491)Bad debt expense670,000 2,547 1,702,000 651,205 Stock-based compensation701,170 347,210 3,019,828 1,341,245 Non-recurring charges— 1,010,123 419,437 1,143,072 Adjusted EBITDA$(864,927) $222,414 $627,798 $1,511,031 The following table presents a reconciliation of net income (loss) to EBITDA and Adjusted EBITDA by business unit: Three Months Ended January 31, 2021 Consolidated AGI Corporate Aspen BSN Pre-Licensure AU Online AU Total USUNet income (loss)$(2,815,266) $(4,537,882) $989,100 1$386,259 $1,375,359 $347,257 Interest expense, net33,436 33,516 — — — (80)Taxes10,460 3,600 — 6,800 6,800 60 Depreciation and amortization535,273 15,540 25,000 467,303 492,303 27,430 EBITDA(2,236,097) (4,485,226) 1,014,100 1860,362 1,874,462 374,667 Bad debt expense670,000 — — 610,000 610,000 60,000 Stock-based compensation701,170 692,244 — (12,468) (12,468) 21,394 Adjusted EBITDA$(864,927) $(3,792,982) $1,014,100 1$1,457,894 $2,471,994 $456,061 1Aspen’s BSN Pre-Licensure program accounted for net income of $1.0 million (which includes $1.8 million of net income from the Phoenix metro, offset by the net loss of ($0.8) million in the Austin and Tampa metros) of the $1.4 million generated at Aspen University. Aspen’s BSN Pre-Licensure program accounted for EBITDA of $1.0 million of the $1.9 million EBITDA generated at Aspen University, operating at an EBITDA margin of 28% - the highest margin unit of the Company. Reconciliation from net income to EBITDA and Adjusted EBITDA for the Aspen BSN Pre-Licensure program delivers the same result, as there were no material interest, taxes, depreciation and amortization expenses incurred in this unit. Definitions Bookings – is defined by multiplying LTV by new student enrollments for each operating unit. Lifetime Value ("LTV") – is calculated as the weighted average total amount of tuition and fees paid by every new student that enrolls in the Company's universities, after giving effect to attrition. Average Revenue per Enrollment ("ARPU") – is defined by dividing total bookings by total new student enrollments for each operating unit. Marketing Efficiency Ratio ("MER") – is defined as revenue per enrollment divided by cost per enrollment. EBITDA Margin – is defined as EBITDA divided by revenues. We believe EBITDA margin is useful for management, analysts and investors as this measure allows a more meaningful comparison between our performance and that of our competitors. EBITDA margin has certain limitations in that it does not take into account the impact to our consolidated statement of operations of certain expenses. Adjusted EBITDA Margin – is defined as Adjusted EBITDA divided by revenues. We believe Adjusted EBITDA margin is useful for management, analysts and investors as this measure allows a more meaningful comparison between our performance and that of our competitors. Adjusted EBITDA margin has certain limitations in that it does not take into account the impact to our consolidated statement of operations of certain expenses. NM – Not meaningful. Subsequent to the call, a transcript of the audiocast will be available from the Company's website at ir.aspen.edu. For additional information on the financial statements and performance, please refer to the Aspen Group, Inc. Form 10-Q for the third quarter of fiscal year 2021 and Q3 2021 Financial Results Presentation published on our website. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our expectations regarding the future success of the BSN Pre-Licensure program, our estimates as to Lifetime Value, the expected future impact of bookings, and ARPU, and the course registrations forecast and revenue growth projections, as adjusted to reflect the anticipated impact of the COVID-19 ‘Wave Two’. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the continued demand for nurses, student attrition, national and local economic factors including the substantial impact of the COVID-19 pandemic on our Aspen nursing programs (other than the pre-licensure program), the delays, side effects or other issues occurring in the manufacturing, delivering and administering the vaccines, the competitive impact from the trend of major non-profit and for-profit universities marketing online family nurse practitioner programs, consolidation among our competitors, the continued effectiveness of our marketing efforts, the effectiveness of our collection efforts and process improvements, unfavorable regulatory changes, including at the state level, and our ability to continue obtaining enrollments at low acquisition costs and keeping teaching costs down. Other risks are included in our filings with the SEC including our Form 10-K for the year ended April 30, 2020, and the prospectus supplement dated August 31, 2020. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. About Aspen Group, Inc.: Aspen Group, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. Investor Relations Contact: Kim RogersManaging DirectorHayden IR385-831-7337 Kim@HaydenIR.com ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS January 31, 2021 April 30, 2020 (Unaudited) Assets Current assets: Cash and cash equivalents$9,987,382 $14,350,554 Restricted cash3,395,068 3,556,211 Accounts receivable, net of allowance of $2,924,887 and $1,758,920, respectively15,832,552 14,326,791 Prepaid expenses1,209,197 941,671 Other receivables— 23,097 Other current assets1,378,173 173,090 Total current assets31,802,372 33,371,414 Property and equipment: Computer equipment and hardware799,826 649,927 Furniture and fixtures1,013,103 1,007,099 Leasehold improvements920,736 867,024 Instructional equipment315,993 301,842 Software7,944,693 6,162,770 Construction in progress907,780 — 11,902,131 8,988,662 Less accumulated depreciation and amortization(4,355,308) (2,841,019)Total property and equipment, net7,546,823 6,147,643 Goodwill5,011,432 5,011,432 Intangible assets, net7,900,000 7,900,000 Courseware, net110,069 111,457 Accounts receivable, net of allowance of $625,963 and $625,963, respectively45,329 45,329 Long term contractual accounts receivable9,986,613 6,701,136 Debt issue cost, net26,389 182,418 Operating lease right of use assets, net11,114,766 6,412,851 Deposits and other assets500,470 355,831 Total assets$74,044,263 $66,239,511 (Continued) ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS (CONTINUED) January 31, 2021 April 30, 2020 (Unaudited) Liabilities and Stockholders’ Equity Current liabilities: Accounts payable$1,155,977 $1,505,859 Accrued expenses2,293,515 537,413 Deferred revenue5,600,371 3,712,994 Due to students2,243,690 2,371,844 Operating lease obligations, current portion2,102,209 1,683,252 Other current liabilities307,677 545,711 Total current liabilities13,703,439 10,357,073 Convertible notes, net of discount of $0 and $1,550,854, respectively— 8,449,146 Operating lease obligations, less current portion9,968,293 5,685,335 Total liabilities23,671,732 24,491,554 Commitments and contingencies Stockholders’ equity: Preferred stock, $0.001 par value; 1,000,000 shares authorized, 0 issued and 0 outstanding at January 31, 2021 and April 30, 2020— — Common stock, $0.001 par value; 40,000,000 shares authorized, 24,939,673 issued and 24,784,187 outstanding at January 31, 2021 21,770,520 issued and 21,753,853 outstanding at April 30, 202024,940 21,771 Additional paid-in capital108,003,022 89,505,216 Treasury stock (155,486 and 16,667 shares at January 31, 2021 and April 30, 2020, respectively)(1,817,414) (70,000)Accumulated deficit(55,838,017) (47,709,030)Total stockholders’ equity50,372,531 41,747,957 Total liabilities and stockholders’ equity$74,044,263 $66,239,511 ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited) Three Months Ended January 31, Nine Months Ended January 31, 2021 2020 2021 2020Revenues$16,624,837 $12,537,940 $48,761,444 $34,981,887 Operating expenses: Cost of revenues (exclusive of depreciation and amortization shown separately below)7,559,951 5,163,007 20,732,254 13,704,121 General and administrative10,644,438 8,625,041 30,723,349 22,613,242 Bad debt expense670,000 2,547 1,702,000 651,205 Depreciation and amortization535,273 475,393 1,552,254 1,710,192 Total operating expenses19,409,662 14,265,988 54,709,857 38,678,760 Operating loss(2,784,825) (1,728,048) (5,948,413) (3,696,873) Other income (expense): Interest expense(33,539) (571,958) (2,018,664) (1,424,607)Other income (expense), net13,558 34,117 (116,820) 189,486 Total other expense, net(19,981) (537,841) (2,135,484) (1,235,121) Loss before income taxes(2,804,806) (2,265,889) (8,083,897) (4,931,994) Income tax expense10,460 15,163 45,090 62,508 Net loss$(2,815,266) $(2,281,052) $(8,128,987) $(4,994,502) Net loss per share - basic and diluted$(0.11) $(0.12) $(0.35) $(0.26) Weighted average number of common stock outstanding - basic and diluted24,544,334 19,420,987 23,354,036 19,046,558 ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITYThree Months Ended January 31, 2021 and 2020(Unaudited) Common Stock Additional Total Shares Amount Paid-InCapital TreasuryStock AccumulatedDeficit Stockholders’EquityBalance at October 31, 202024,416,539 $24,417 $105,092,551 $— $(53,022,751) $52,094,217 Stock-based compensation— — 701,170 — — 701,170 Common stock issued for stock options exercised for cash447,134 447 2,180,352 (1,817,414) — 363,385 Common stock issued for vested restricted stock units74,000 74 (74) — — — Common stock issued for services2,000 2 19,898 — — 19,900 Amortization of warrant based cost— — 9,125 — — 9,125 Net loss— — — — (2,815,266) (2,815,266)Balance at January 31, 202124,939,673 $24,940 $108,003,022 $(1,817,414) $(55,838,017) $50,372,531 Common Stock Additional Total Shares Amount Paid-InCapital TreasuryStock AccumulatedDeficit Stockholders’EquityBalance at October 31, 201919,142,316 $19,142 $69,781,363 $(70,000) $(44,763,415) $24,967,090 Stock-based compensation— — 737,820 — — 737,820 Common stock issued for cashless stock options exercised8,352 9 (9) — — — Common stock issued for stock options exercised for cash121,407 121 530,547 — — 530,668 Amortization of warrant based cost— — 9,125 — — 9,125 Amortization of restricted stock issued for services— — 24,398 — — 24,398 Restricted stock issued for services, subject to vesting40,000 40 (40) — — — Common stock issued for equity raise, net of underwriter costs of $1,222,3712,415,000 2,415 16,042,464 — — 16,044,879 Other offering costs— — (51,282) — — (51,282)Beneficial conversion feature on convertible debt— — 1,692,309 — — 1,692,309 Common stock short swing reclamation— — 5,433 — — 5,433 Net loss— — — — (2,281,052) (2,281,052)Balance at January 31, 202021,727,075 $21,727 $88,772,128 $(70,000) $(47,044,467) $41,679,388 ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (CONTINUED)Nine months ended January 31, 2021 and 2020(Unaudited) Common Stock Additional Total Shares Amount Paid-InCapital TreasuryStock AccumulatedDeficit Stockholders’EquityBalance at April 30, 202021,770,520 $21,771 $89,505,216 $(70,000) $(47,709,030) $41,747,957 Stock-based compensation— — 3,019,828 — — 3,019,828 Common stock issued for stock options exercised for cash1,364,721 1,365 4,394,749 (1,817,414) — 2,578,700 Common stock issued for cashless stock options exercised22,339 22 (22) — — — Common stock issued for conversion of Convertible Notes1,398,602 1,399 9,998,601 — — 10,000,000 Common stock issued for vested restricted stock units206,109 206 (206) — — — Common stock issued for warrants exercised for cash192,049 192 1,081,600 — — 1,081,792 Common stock issued for services2,000 2 19,898 — — 19,900 Modification charge for warrants exercised— — 25,966 — — 25,966 Amortization of warrant based cost— — 27,375 — — 27,375 Cancellation of treasury stock(16,667) (17) (69,983) 70,000 — — Net loss— — — — (8,128,987) (8,128,987)Balance January 31, 202124,939,673 $24,940 $108,003,022 $(1,817,414) $(55,838,017) $50,372,531 Common Stock Additional Total Shares Amount Paid-InCapital TreasuryStock AccumulatedDeficit Stockholders’EquityBalance at April 30, 201918,665,551 $18,666 $68,562,727 $(70,000) $(42,049,965) $26,461,428 Stock-based compensation— — 1,627,304 — — 1,627,304 Common stock issued for cashless stock options exercised190,559 191 (191) — — — Common stock issued for stock options exercised for cash234,233 234 768,147 — — 768,381 Common stock issued for cashless warrant exercise76,929 77 (77) — — — Amortization of warrant based cost— — 27,690 — — 27,690 Amortization of restricted stock issued for services— — 97,748 — — 97,748 Restricted stock issued for services, subject to vesting144,803 144 (144) — — — Common stock issued for equity raise, net of underwriter costs of $1,222,3712,415,000 2,415 16,042,464 — — 16,044,879 Other offerings costs— — (51,282) — — (51,282)Beneficial conversion feature on convertible debt— — 1,692,309 — — 1,692,309 Common stock short swing reclamation— — 5,433 — — 5,433 Net loss— — — — (4,994,502) (4,994,502)Balance at January 31, 202021,727,075 $21,727 $88,772,128 $(70,000) $(47,044,467) $41,679,388 ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited) Nine Months Ended January 31, 2021 2020Cash flows from operating activities: Net loss$(8,128,987) $(4,994,502)Adjustments to reconcile net loss to net cash used in operating activities: Bad debt expense1,702,000 651,205 Depreciation and amortization1,552,254 1,710,192 Stock-based compensation3,019,828 1,782,472 Amortization of warrant based cost27,375 27,690 Loss on asset disposition— 3,918 Amortization of debt discounts1,550,854 182,218 Amortization of debt issue costs156,029 88,825 Modification charge for warrants exercised25,966 — Common stock issued for services19,900 97,748 Changes in operating assets and liabilities: Accounts receivable(6,493,238) (7,104,911)Prepaid expenses(267,526) (567,192)Other receivables23,097 395 Other current assets(1,205,083) (173,090)Deposits and other assets(185,599) 280,091 Accounts payable(349,882) (908,083)Accrued expenses1,756,102 426,567 Deferred rent— (17,805)Due to students(128,154) 1,137,244 Deferred revenue1,887,377 3,237,878 Other current liabilities(238,032) 313,875 Net cash used in operating activities(5,275,719) (3,825,265)Cash flows from investing activities: Purchases of courseware and accreditation(31,330) (11,001)Purchases of property and equipment(2,877,758) (1,929,878)Net cash used in investing activities(2,909,088) (1,940,879)Cash flows from financing activities: Proceeds from warrants exercised1,081,792 — Proceeds from stock options exercised2,578,700 768,381 Proceeds from sale of common stock net of underwriter costs— 16,044,879 Disbursements for equity offering costs— (51,282)Common stock short swing reclamation— 5,433 Net cash provided by financing activities3,660,492 16,767,411 (Continued) ASPEN GROUP, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)(Unaudited) Nine Months Ended January 31, 2021 2020Net (decrease) increase in cash, cash equivalents and restricted cash$(4,524,315) $11,001,267 Cash, cash equivalents and restricted cash at beginning of period17,906,765 9,967,752 Cash, cash equivalents and restricted cash at end of period$13,382,450 $20,969,019 Supplemental disclosure cash flow information Cash paid for interest$310,958 $979,792 Cash paid for income taxes$49,008 $110,307 Supplemental disclosure of non-cash investing and financing activities Common stock issued for conversion of Convertible Notes$10,000,000 $— Right-of-use lease asset offset against operating lease obligations$3,914,640 $7,693,268 Common stock issued for services$— $178,447 Beneficial conversion feature on convertible debt$— $1,692,309 The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying consolidated balance sheet to the total amounts shown in the accompanying unaudited consolidated statements of cash flows: January 31, 2021 January 31, 2020 Cash and cash equivalents$9,987,382 $20,512,808 Restricted cash3,395,068 456,211 Total cash, cash equivalents and restricted cash$13,382,450 $20,969,019

  • ACCESSWIRE

    Aspen Group, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 16, 2021 / Aspen Group, Inc. (NASDAQ:ASPU) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on March 16, 2021 at 4:30 PM Eastern Time.

  • Aspen University Receives Approval to Open BSN Pre-Licensure Program in Nashville, Tennessee
    GlobeNewswire

    Aspen University Receives Approval to Open BSN Pre-Licensure Program in Nashville, Tennessee

    Marketing to First-Year Prerequisite Students to Begin Effective ImmediatelyNEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Aspen Group, Inc. ("AGI") (Nasdaq: ASPU), an education technology holding company, today announced that Aspen University received the final required state and board of nursing regulatory approvals for their new Bachelor of Science in Nursing (BSN) Pre-Licensure program in Nashville, Tennessee, with permission to commence marketing and begin to enroll first-year pre-requisite students effective immediately. "Aspen University's BSN Pre-Licensure degree is our highest LTV program. Following the Nashville opening, we will have successfully launched five locations in four states since 2018. We’re targeting to begin our initial (years 2-3) core program term in Nashville in August 2021, in clinical partnership with NorthCrest Medical Center, Trust Point Hospital, and Nashville General Hospital, among others," stated Michael Mathews, Aspen Group Chairman and CEO. "The majority of Aspen University's BSN Pre-Licensure students are part-time and full-time working adults, and we strive to cater to their needs. We offer the majority of our BSN Pre-Licensure program curriculum online, together with an on-ground applied learning component offered with day and night/weekend program options, unlike the traditional on-campus five-day-a-week day program format. In addition to affordable tuition and flexible payment options, the ability to work while attaining a life-changing degree makes our program very popular. Aspen Group's strategic roadmap targets having 12 operational BSN Pre-licensure locations throughout the western and southern United States by 2025." The new Aspen University location in Nashville will follow the BSN Pre-Licensure structure established initially in Phoenix. Nashville will operate as a full-time, accelerated three-year (nine semester) program specifically designed for students who do not currently hold a state registered nursing license and/or who have no prior nursing experience. The 120-credit program is offered at a total cost of attendance of less than $50,000. Students enter one of two program components: Year 1 - the Pre-Professional Nursing (PPN) component is offered fully online for students that have completed less than the required 41 pre-requisite general education credits. Year 1 tuition is $7,000 or less, depending on the number of credits needed to satisfy the pre-requisite requirements. Students can use Aspen’s monthly payment method to pay Year 1 courses;Years 2-3 - the Nursing Core component which prepares students to sit for the NCLEX. The Nashville site will be located at 1809 Dabbs Avenue, which is situated on Interstate 40 east of downtown Nashville, four miles west of the Nashville airport. Aspen University will begin enrolling first year PPN students in Nashville starting in April 2021; Core nursing students (Years 2-3) in August, 2021. About Aspen Group, Inc. Aspen Group, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. For more information, visit www.aspu.com. Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our plans with respect to new campus openings, and the timing of our Nashville program. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the continued demand of nursing students for the new programs, national and local economic factors including the substantial impact of the COVID-19 pandemic on the economy, and the competitive impact from the trend of public non-profit universities offering online education. Other risks are included in our filings with the SEC including our Form 10-K for the year ended April 30, 2020 and the prospectus supplement dated August 31, 2020. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Contact Information: Hayden IRKimberly Rogers(385) 831-7337Kim@HaydenIR.com